UltraLift III — HIFU Non-Surgical Facial Lifting

The UltraLift III is a next-generation HIFU (High Intensity Focused Ultrasound) device dedicated to non-invasive facial lifting, developed by NeoCure for skin tightening and structural facial lifting. The device combines three interchangeable cartridges (1.5mm, 3mm, 4.5mm) allowing precise multi-stage treatment of dermis and SMAS. Specifications include: high-frequency piezoelectric transducer 4-5 MHz, adjustable energy density 2000-3000 W/cm², focused thermal coagulation points 65-75°C, high-resolution touchscreen with continuous thermal feedback, integrated epidermal cooling, ergonomic design for extended facial application. The UltraLift III is FDA cleared for facial lifting, adipose tissue destruction, and non-invasive skin tightening.

THREE INTERCHANGEABLE CARTRIDGE SYSTEM:

• 1.5mm cartridge: epidermal focusing, texture smoothing, pore refinement
• 3mm cartridge: deep dermis, global tightening, wrinkle reduction
• 4.5mm cartridge: SMAS targeting, structural lifting, jowl elimination
• Change cartridge < 1 min, allowing complete protocol in single session

ADVANCED TOUCHSCREEN:

• 7-inch high-resolution touchscreen
• Intuitive software: depth selection, thermal coagulation point density, session timing
• Real-time thermal feedback display (dermal temperature)
• Automatic thermal coagulation point counter (number delivered)
• Patient record saving: personalized protocol, treatment history
• Per-cartridge automatic calibration

INTEGRATED COOLING:

• Continuous contact cooling system of epidermis during treatment
• Maintains epidermal temperature < 45°C while allowing dermal depth to reach 65-75°C
• Safety: prevents superficial burn, increases patient comfort
• Sometimes referred to as "epidermal cooling" or "cryogen contact cooling"

OPTIMIZED ACOUSTIC TRANSMISSION:

• Specialized NeoCure acoustic coupling gel (optimal transducer-skin contact)
• Minimizes acoustic signal attenuation, maximizes energy penetration
• Reduces air-interface perturbations (acoustic artifacts)

ERGONOMIC DESIGN:

• Lightweight handpiece (300g), slim handle easy handling for extended (60-90min sessions)
• Flexible articulation cable, allows access to all facial zones (forehead, temples, jawline, neck)
• Compact cartridge head design for practitioner visibility of treatment zone
• Non-burning exterior, patient contact surface safe temperature

The UltraLift III operates according to focused HIFU ultrasound principles:

PIEZO-ELECTRIC TRANSDUCER:

• Quartz piezo crystal generates electrical oscillation 4-5 MHz (4-5 million cycles/second)
• Oscillation converted to mechanical vibrations via piezo-effect → propagated ultrasonic waves
• Spherical transducer ~15mm diameter, integrated acoustic focusing lens

FREQUENCY 4-5 MHZ:

• Optimal compromise: tissue penetration 15-20mm (reaches SMAS) + precise focusing
• Lower frequency (1-2 MHz) = deeper penetration, less precise focusing
• Higher frequency (10 MHz) = less depth penetration, very fine focusing (superficial only)

ACOUSTIC FOCUSING:

• Spherical lens concentrates ultrasound wave into narrow focal point (~1-2mm focal diameter)
• At focal depth, maximum energy density (2000-3000 W/cm²), generates thermal coagulation points
• Before/after focal point, intensity reduced minimal damage

THERMAL COAGULATION POINT CREATION:

• Concentrated ultrasonic energy = heat conversion via tissue absorption
• Local focal point temperature reaches 65-75°C in < 1 second
• Temperature coagulates proteins (collagen, elastin), creating micro-necrotic focal point
• Each shot (0.8-1.2 seconds sonication) = one thermal coagulation point ~ 1-2mm diameter

DEPTH CONTROL:

• Three cartridges: 1.5mm, 3mm, 4.5mm focal depth by CHANGING depth
• Transducer physically "offset" per-cartridge (different acoustic lens geometry)
• Practitioner selects desired cartridge → automatic correct focal depth

PARAMETRIC ADJUSTMENTS:

• Energy density: adjustable 1500-3000 W/cm² (higher = more heat, tissue damage)
• Sonication duration: 0.5-1.5 seconds (0.8-1.2 sec optimal)
• Shot interval: 2-5 seconds (3-4 sec optimal for cooling)
• Number of shots: 50-200 per cartridge per zone (depends on zone size, desired thermal coagulation point density)

TEMPERATURE FEEDBACK:

• Integrated thermistor (temperature sensor) monitoring dermal temperature
• Real-time display on touchscreen
• Automatic alert if temperature exceeds safety threshold (> 50°C typically)
• Historical data: saved temperature curve per-treatment for post-analysis

COMPLETE SESSION PROTOCOL:

• Face cleansing with warm shower (rinse cosmetic product traces)
• Application of anesthetic cream (2.5% lidocaine) if low pain tolerance
• Wait 20-30 min for anesthetic penetration (optional)

• Pre-marking treatment zones (with eyeliner marker): cheeks, mandible, neck
• Baseline photography pre-treatment (documentation)

• Apply NeoCure acoustic gel generously to entire prepared facial zone
• Gel ensures optimal acoustic transmission, transducer-skin coupling
• Avoid air bubbles (troubleshoot signal)

• Select 3mm cartridge on touchscreen
• Settings: 2500 W/cm² density, 1.0 sec sonication, 3.5 sec interval
• Thermal coagulation point density: 5-6 points/cm² (optimal plateau)
• Treatment zones: bilateral cheeks (100-120 thermal coagulation points), jawline (80-100 points)
• Pass 1: systematic coverage cheek-to-jaw
• Pass 2: slight offset repeat (2-3cm shift) for optimal 5-6 points/cm² density coverage
• Monitoring: screen thermal feedback, verify 45-55°C target dermis
• Pain management: continuous patient feedback, pause if excessive discomfort

• Change to 1.5mm cartridge (easy switch < 1 min)
• Settings: 2500 W/cm² density, 1.0 sec sonication, 3.5 sec interval
• Thermal coagulation point density: 4-5 points/cm² (moderate, as 1.5mm very painful)
• Focus zones: forehead, cheekbones, neck decollete
• Pass 1: selective coverage zones (not mandatory entire face if extreme pain)
• Pain management: enhanced anesthesia, patient breathing important

• Change to 4.5mm cartridge
• Settings: 2500 W/cm² density, 1.0 sec sonication, 3.5 sec interval
• Thermal coagulation point density: 5 points/cm² (moderate for SMAS safety)
• Focus zones: mandibular (jowl region) priority, neck (platysma)
• Pass 1-2: dense coverage jowl/jawline (critical zone for structural lift)
• Pain management: typically moderate, tolerable

• Remove residual gel with damp cloth
• Rinse gel with warm water
• Pat face dry gently

• Photograph post-treatment immediately (document baseline erythema)
• Application aloe vera gel or light moisturizer (calm erythema)
• Application SPF30+ sunscreen (mandatory sun protection)
• Post-treatment counseling (see FAQ section)

TOTAL SESSION DURATION: 60-90 minutes (depends on zone size, thermal coagulation point density, patient pain tolerance)

REPEATED SESSIONS:

• Session 1 (week 0): complete protocol 3 cartridges
• Session 2 (week 6-8): generally 1.5mm+3mm only (skip 4.5mm repeat for safety)
• Session 3 (week 12-16): 3mm only (touch-up, very conservative)
• Maintenance touch-up (month 6-12 post-series): 1 session 3mm+4.5mm annually

CLINICAL PRECAUTIONS:

• Always test-patch reduced zone 24h before complete treatment if patient new to HIFU
• Strict temperature monitoring: alert if > 50°C
• Never exceed 6-8 points/cm² to avoid paradoxical laxity effect
• Respect minimum 4 weeks between sessions (healing)

DOCUMENTED UltraLift III EFFICACY:

MONOCENTRIC CLINICAL STUDIES:

• Brand studies report 70-85% patient satisfaction "good to excellent" improvement
• Measurable structural lifting: 2-3mm observable mandibular angle improvement
• Jowl volume reduction: 50-70% visible Grade II-III cellulite/laxity reduction
• Timeline: visible improvement begins week 2-4, peak 5-6 months

OBJECTIVE MEASUREMENTS:

• Ultrasound imaging: 15-25% dermal thickening documented 3-6 months
• Photography analysis: 30-50% measurable wrinkle reduction (light-based 3D analysis)
• Elasticity testing (cutometer/durometer): 20-40% firmness improvement

RESULT DURATION:

• Improvement plateau: 6-9 months post-complete protocol
• Progressive degradation: begins ~9-12 months, declines ~1%/month thereafter
• Plateau duration: 12-15 months without touch-up
• Maintenance touch-ups: recommended annually 1 session for durable results

RARECOMPLICATIONS (< 1% with proper protocol):

• Superficial burn: < 0.5% (excellent safety record)
• Persistent erythema: < 1% (generally transitory 2-4 days)
• Temporary tactile paresthesia: < 0.5% (generally resolves 2-8 weeks)
• Paradoxical laxity (over-dose): < 0.1% if standard protocol respected

IDEAL POPULATION:

• Age: 35-65 years (best collagenic response)
• Laxity severity: mild-moderate (Grade II-III)
• Phototype: I-V (VI adaptable intensity but possible)
• Expectations: realistic, acceptance of 3-6 month timeline, engagement with annual touch-ups

SUCCESS PREDICTOR FACTORS:

• Younger age: better response
• Good healing history (no uncontrolled diabetes)
• Non-smoker: tobacco reduces collagen synthesis
• Good compliance: respect post-treatment restrictions
• Photo-protection: strict sunscreen (new skin collagen very photosensitive)